ATC code none PubChem CID 5496659 UNII S173RED00L Molar mass 446.498 g/mol | CAS Number 193153-04-7 ChemSpider 4593439 ChEMBL CHEMBL46618 | |
 | ||
Otamixaban (INN) is an experimental injectable anticoagulant direct factor Xa inhibitor that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial.
References
Otamixaban Wikipedia(Text) CC BY-SA